Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma Clinical Trials in Atlanta, Georgia

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer